Krane Funds Advisors LLC Legend Biotech Corp Transaction History

Krane Funds Advisors LLC

  • $2.34 Billion
  • Q1 2024

A detailed history of Krane Funds Advisors LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Krane Funds Advisors LLC holds 20,163 shares of LEGN stock, worth $933,546. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,163
Previous 20,440 1.36%
Holding current value
$933,546
Previous $1.23 Million 8.06%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024
SELL
$55.06 - $69.99 $15,251 - $19,387
-277 Reduced 1.36%
20,163 $1.13 Million
Q4 2023

Feb 14, 2024
BUY
$57.25 - $69.74 $25,819 - $31,452
451 Added 2.26%
20,440 $1.23 Million
Q3 2023

Nov 13, 2023
SELL
$63.16 - $76.5 $4,105 - $4,972
-65 Reduced 0.32%
19,989 $1.34 Million
Q2 2023

Aug 11, 2023
SELL
$46.28 - $75.01 $122,040 - $197,801
-2,637 Reduced 11.62%
20,054 $1.38 Million
Q1 2023

May 12, 2023
BUY
$43.42 - $57.37 $11,376 - $15,030
262 Added 1.17%
22,691 $1.15 Million
Q4 2022

Feb 10, 2023
SELL
$38.8 - $55.46 $14,549 - $20,797
-375 Reduced 1.64%
22,429 $1.12 Million
Q3 2022

Nov 14, 2022
BUY
$38.15 - $57.1 $48,221 - $72,174
1,264 Added 5.87%
22,804 $930,000
Q2 2022

Aug 11, 2022
SELL
$33.54 - $55.0 $23,075 - $37,840
-688 Reduced 3.1%
21,540 $1.19 Million
Q1 2022

May 11, 2022
BUY
$31.02 - $48.18 $56,425 - $87,639
1,819 Added 8.91%
22,228 $808,000
Q4 2021

Feb 10, 2022
BUY
$41.14 - $56.98 $828,148 - $1.15 Million
20,130 Added 7215.05%
20,409 $951,000
Q2 2021

Aug 12, 2021
SELL
$25.8 - $41.09 $2,657 - $4,232
-103 Reduced 26.96%
279 $11,000
Q4 2020

Feb 11, 2021
BUY
$25.8 - $32.39 $9,855 - $12,372
382 New
382 $11,000

Others Institutions Holding LEGN

# of Institutions
213
Shares Held
63.6M
Call Options Held
1.09M
Put Options Held
525K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.75B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Krane Funds Advisors LLC Portfolio

Follow Krane Funds Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email